1. AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer's disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation. (7th December 2020) Authors: Aisen, Paul S.; Zhou, Jin; Irizarry, Michael C.; Kramer, Lynn D; Swanson, Chad J.; Dhadda, Shobha; Rabe, Martin; Krause, Stephen; Li, David JianJun; Raman, Rema; Donohue, Michael C.; Sethuraman, Gopalan; Johnson, Keith A.; Sperling, Reisa A. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AHEAD 3‐45 study: Preliminary screening and baseline characteristics from a placebo‐controlled, double‐blind study evaluating lecanemab in participants with preclinical Alzheimer's disease and elevated (A45 trial) and intermediate (A3 trial) amyloid. (31st December 2021) Authors: Zhou, Jin; Irizarry, Michael C; Kramer, Lynn D; Swanson, Chad J; Roberts, Claire; Dhadda, Shobha; Li, David JianJun; Rabe, Martin; Krause, Stephen; Raman, Rema; Donohue, Michael C; Sethuraman, Gopalan; Johnson, Keith A.; Sperling, Reisa A.; Aisen, Paul S Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease. (31st December 2021) Authors: Lynch, Shau Yu; Irizarry, Michael C; Dhadda, Shobha; Li, David JianJun; Kanekiyo, Michio; Bogoslovsky, Tanya; Gee, Michelle; Reyderman, Larisa; Kaplow, June; Rabe, Martin; Hodgkinson, Mark; Kramer, Lynn D; Hampel, Harald; Swanson, Chad J Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Derivation and evaluation of signatures using plasma β‐amyloid and pTau‐181 for brain amyloid‐β detection. (20th December 2022) Authors: Devanarayan, Viswanath; Dhadda, Shobha; Koyama, Akihiko; Swanson, Chad J; Hampel, Harald; Irizarry, Michael C; Kramer, Lynn D Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 5 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer's Disease Studies. (20th December 2022) Authors: Grill, Joshua; Molina‐Henry, Doris P.; Sperling, Reisa A.; Dhadda, Shobha; Tranotti, Kate; Harris, Russell; Devins, Theresa; Swanson, Chad J; Kanekiyo, Michio; Gee, Michelle; Irizarry, Michael C; Kramer, Lynn D; Aisen, Paul; Raman, Rema Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lecanemab (BAN2401) Infusion Reactions and Immunogenicity: Results from Randomized Phase 2 Study and an Open‐Label Extension (OLE). (20th December 2022) Authors: Landry, Ishani; Kanekiyo, Michio; Aluri, Jagadeesh; Li, David JianJun; Hussein, Ziad; Reyderman, Larisa; Dhadda, Shobha; Swanson, Chad J; Irizarry, Michael C; Kramer, Lynn D Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 10 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Plasma Aβ 42:40 ratio tracks with changes in brain amyloid PET SUVr in the core and open label extension of the phase 2 proof of concept study ban2401‐g000‐201 following treatment with lecanemab in subjects with early Alzheimer's disease. (31st December 2021) Authors: Swanson, Chad J; Kanekiyo, Michio; Kaplow, June; Dhadda, Shobha; Irizarry, Michael C; Koyama, Akihiko; Li, David JianJun; Verbel, David; Gordon, Robert; Heanue‐Travers, Helena; Hodgkinson, Mark; Kramer, Lynn D Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Preliminary assessment of the clinical effects of lecanemab following 18 months of treatment in the open label extension of the phase 2 proof of concept study, BAN2401‐G000‐201, in subjects with early Alzheimer's disease. (31st December 2021) Authors: Swanson, Chad J; Dhadda, Shobha; Irizarry, Michael C; Kanekiyo, Michio; Li, David JianJun; Kaplow, June; Gordon, Robert; Heanue‐Travers, Helena; Hodgkinson, Mark; Kramer, Lynn D Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Preliminary assessment of the clinical effects of lecanemab following 18 months of treatment in the open label extension of the phase 2 proof of concept study, BAN2401‐G000‐201, in subjects with early Alzheimer's disease. (31st December 2021) Authors: Swanson, Chad J; Dhadda, Shobha; Irizarry, Michael C; Kanekiyo, Michio; Li, David JianJun; Kaplow, June; Gordon, Robert; Heanue‐Travers, Helena; Hodgkinson, Mark; Kramer, Lynn D Journal: Alzheimer's & dementia Issue: Volume 17:(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Strategies for diverse participant recruitment to a preclinical Alzheimer's Disease prevention trial: The AHEAD study. (20th December 2022) Authors: Molina‐Henry, Doris P.; Grill, Joshua; Sperling, Reisa A.; Aisen, Paul; Clanton, Taylor; Devins, Theresa; Dhadda, Shobha; Glover, Crystal M; Irizarry, Michael C; Johnson, Keith A.; Kirn, Dylan; Kramer, Lynn D; Shum, Leona K; Zhou, Jin; Raman, Rema Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 11 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗